UAE –: A new Executive Education program co-designed by top-ranked business school, HEC Paris in Qatar and Weill Cornell Medicine-Qatar – both members of Qatar Foundation – will target healthcare professionals with the aim of driving systems-level management expertise and accelerating patient outcomes in the Kingdom and across the region.

The Executive Certificate in Healthcare Management and Policy forms part of Qatar’s commitment to transform into a thriving, diversified knowledge-based economy. Specifically targeting healthcare management, the new program has been designed to optimize practitioner understanding of effective healthcare strategy, systems, operations, and innovation at an integrated, systems level. In essence, it delivers system-wide efficiencies and enhanced outcomes for patients in the region.

The program fully leverages the combined expertise of HEC Paris, which is ranked #1 in the Financial Times European Business Schools Ranking 2021, and Weill Cornell Medicine-Qatar, one of the most respected and highly ranked medical research centers in the United States and the Gulf region.

Healthcare leaders and decision-makers participating in the program will take two five-day modules beginning in January 2022

The first module is delivered in Doha and focuses on healthcare management, exploring critical leadership challenges in modern organizations and strategies for empowering employees. This session introduces foundational frameworks for interaction between healthcare system players, strategic decision making, operational process design as a strategy enabler and approaches to guide development of patient-centric services. It will also examine how digital transformation drives healthcare innovation and explore the role of entrepreneurial efforts.

The second module is delivered in New York, where participants will focus on the function, components and indicators of healthcare policy and the basis and principles of health economics and incentives to pay for care delivery. It looks at healthcare financing, priorities and forecast expenditure as well as the measurement and evaluation of new treatments benefits. The future of healthcare, and the role of machine learning in optimizing diagnosis and treatment of diseases will also be explored. The session will also feature visits to major healthcare providers in New York.

The program concludes with an experiential learning project that sees participants work closely with a real-world healthcare organization to solve a specific managerial or policy challenge.

Dean of HEC Paris in Qatar, Dr. Pablo Martin de Holan, welcomes the new program saying: “The partnership with Weill Cornell Medicine-Qatar brings together two members of the Qatar Foundation family and underlines our commitment to the country and the excellence in healthcare provision integral to the Qatar National Vision.”

“Healthcare spending frequently exceeds 10% of advanced economies’ GDPs yet does not necessarily translate into satisfactory levels of population health. These systems often struggle to ensure timely and affordable access to quality care. At the same time, increasing life expectancies and lifestyle changes alter the nature of services that people expect to navigate these challenges.”

Dean of Weill Cornell Medicine-Qatar, Dr. Javaid Sheikh stresses the critical role of collaborative initiatives in tackling country-level challenges: “The new program harnesses the combined expertise of two of the world’s foremost education institutions to address the myriad complexities in providing effective and sustainable healthcare solutions. This is a significant step forward in providing Qatar’s healthcare executives with comprehensive and integrated knowledge that spans all aspects of customer-centric healthcare delivery and innovation, as well as the operational, management and policy dimensions of sustainable growth.”

“Our goal is to empower these leaders to guide their organizations more efficiently in order to successfully navigate new realities and emerging risks and opportunities.”

-Ends-

About Weill Cornell Medicine - Qatar 

Weill Cornell Medicine - Qatar is a partnership between Cornell University and Qatar Foundation. It offers a comprehensive six-year medical program leading to the Cornell University M.D. degree with teaching by Cornell and Weill Cornell faculty and by physicians at Hamad Medical Corporation (HMC), Aspetar Orthopedic and Sports Medicine Hospital, the Primary Health Care Corporation, the Feto Maternal Center, and Sidra Medicine, who hold Weill Cornell appointments. Through its biomedical research program, WCM-Q is building a sustainable research community in Qatar while advancing basic science and clinical research. Through its medical college, WCM-Q seeks to provide the finest education possible for medical students, to improve health care both now and for future generations, and to provide high quality health care to the Qatari population.

HEC Paris:

Founded in 1881 by the Paris Chamber of Commerce and Industry, HEC Paris brings together 140 permanent professors, 4,500 students and 8,000 managers in executive education programs every year.

As leaders of impactful learning, HEC Paris has been committed to excellence and impact in research, teaching and thought leadership while delivering transformation and support in addressing the disciplines that matter in today’s complex global economic situation.

In 2010, HEC Paris joined Qatar Foundation to bring world-class Executive Education programs and research activity to Doha and the region. HEC Paris launched Qatar’s first international EMBA, which is currently ranked number 3 worldwide by the Financial Times, and the Specialized Master’s in Strategic Business Unit Management (SBUM). HEC Paris is also a world leader in custom-designed programs, and works with clients in Qatar and the region to design and deliver executive programs that address current business challenges.

The programs and research activities of HEC Paris in Qatar build corporate competitiveness within the global economy and are fully aligned with Qatar National Vision 2030 to support the transformation of Qatar into an advanced, competitive and knowledge-based economy. Corporate partnerships have also played a key part in HEC Paris’ mission of bringing about regional economic transformation by developing business talent, managers and leaders who can meet the societal and environmental challenges of the future.   http://www.qatar.exed.hec.edu/ 

For more info, please contact:
qatar-healthcare@hec.fr / +974 4141 3200
Or
Hanan Lakkis
Associate Director, Media and Publications
Weill Cornell Medicine - Qatar
Mobile: +974 55536564
hyl2004@qatar-med.cornell.edu 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.